共 37 条
[21]
Letiexhe MR, Scheen AJ, Gerard PL, Desaive C., Lefebvre PJ, Insulin secretion, clearance and action before and after gastroplasty in severely obese subjects, Int J Obesity, 18, pp. 295-300, (1994)
[22]
Castillo MJ, Scheen AJ, Letiexhe MR, Lefebvre PJ, How to measure insulin clearance, Diabetes Metab Rev, 10, pp. 119-150, (1994)
[23]
Bergman RN, Towards physiological understanding of glucose tolerance. Minimal‐model approach, Diabetes, 38, pp. 1512-1527, (1989)
[24]
Scheen AJ, Paquot N., Castillo MJ, Lefebvre PJ, How to measure insulin action in vivo, Diabetes Metab Rev, 10, pp. 151-158, (1994)
[25]
Zerbe GO, Randomization analysis of the completely randomized design extended to growth and response curves, Journal of the American Statistical Association, 74, pp. 215-221, (1979)
[26]
Giugliano D., de Rosa N., Di Maro G., Marfella R., Acampora R., Buoninconti R., Et al., Metformin improves glucose, lipid metabolism, and reduces blood pressure in hypertensive, obese women, Diabetes Care, 16, pp. 1387-1390, (1993)
[27]
Landin K., Tengborn L., Smith U., Treating insulin resistance in hypertension with metformin reduces both blood pressure and metabolic risk factors, J Internal Med, 229, pp. 181-187, (1991)
[28]
Saad MF, Anderson RL, Laws A., Watanabe RM, Kades WW, Chen Y-DI, Et al., A comparison between the minimal model and the glucose clamp in the assessment of insulin sensitivity across the spectrum of glucose tolerance, Diabetes, 43, pp. 1114-1121, (1994)
[29]
Perriello G., Misericordia P., Volpi E., Santucci A., Santucci C., Ferrannini E., Et al., Acute antihyperglycemic mechanisms of metformin in NIDDM. Evidence for suppression of lipid oxidation and hepatic glucose production, Diabetes, 43, pp. 920-928, (1994)
[30]
Haffner SM, Stern MP, Watanabe RN, Bergman RN, Relationship of insulin clearance and secretion to insulin sensitivity in non‐diabetic Mexican Americans, Eur J Clin Invest, 22, pp. 147-153, (1992)